Fed Rate Hike Expectations Resurface as Inflation Surge Shifts Market Outlook Over 50 Indian Companies Return to Profitability in Q4 Amid Market Volatility Adani Green Tata Tech Among Turnaround Stories Political Risk in UK Andy Burnhams Rise and the Churn in Establishment Power Dynamics BP Boardroom Turmoil Deepens as Chairman Manifold Departs Nio Shares Surge 10 on Launch of First Flagship Electric Vehicle in Over Two Years Neogen Corporation NEOG Q1 2026 Earnings Strong Profit Beat Offsets Flat Revenue Iveda Solutions Q2 2024 Earnings EPS Beats Estimates by 412 Stock Declines ADXN Q1 2024 Earnings PreRevenue Biotech Reports Net Loss Amid Ongoing RD Efforts YQ Q3 2025 Earnings Negative EPS and Stock Decline Amid Ongoing Challenges AAON Q1 2026 Earnings Stellar EPS Beat Highlights Strong Execution Despite Stock Dip Geron Corporation GERN Slips 079 Approaches Key Support Level Essent Group Ltd ESNT Dips 19 as Shares Test Key Support Levels CO2 Energy Transition Corp Warrant NOEMW Surges 2453 as Key Support and Resistance Levels Emerge ACI Worldwide ACIW Edges Lower Holding Above Key Support Zone Olin Corporation OLN Gains Momentum Stock Rises 281 Amid Sector Dynamics Passage Bio Inc PASG Edges Higher as Buyers Defend Key Support Level Reid Hoffman and Siddhartha Mukherjee Launch AI Cancer Research Startup Manas AI with 246 Million RIG Q1 2026 Earnings EPS Misses Expectations as Offshore Drilling Market Faces Headwinds Gap and American Eagle Stocks Slide After Earnings Retailers Say Economy Isnt to Blame Indias Competition Regulator Approves Indovida IndiaEPL Merger REI Q1 2026 Earnings EPS Surges Past Estimates Stock Gains 31 Sila Realty Trust SILA Holds Steady Near Resistance in LowVolume Trade ADAMH Q1 2026 Earnings EPS Surges 75 Above Estimates SENEB Q1 2026 Earnings EPS Reaches 619 Highlighting Operational Resilience ITRN Q1 2026 Earnings EPS Beat Driven by Strong Subscriber Growth and Operational Efficiency LCID Q1 2026 Earnings WiderThanExpected Loss as Ramps Remain Costly Haemonetics HAE Q1 2026 Earnings Slight EPS Beat Amidst Steady Operational Performance Monte Rosa Therapeutics GLUE Q1 2026 Earnings EPS Miss Highlights Ongoing ClinicalStage Costs Stock Gains Modestly CLMT Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds